|
AU2008237507B2
(en)
*
|
2007-04-03 |
2014-03-20 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
|
ES2386851T3
(es)
|
2007-11-30 |
2012-09-03 |
Novartis Ag |
Alquil (C2-C5)-imidazol-bisfosfonatos
|
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
TWI496779B
(zh)
*
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
|
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
EP2389373B1
(en)
|
2009-01-21 |
2017-05-17 |
Rigel Pharmaceuticals, Inc. |
Derivatives of n2-(3-pyridyl or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
|
|
AP2799A
(en)
|
2009-06-05 |
2013-11-30 |
Pfizer |
1-(Piperidin-4-YL)-pyrazole derivatives as GPR 119modulators
|
|
JP5641664B2
(ja)
|
2009-10-30 |
2014-12-17 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ |
イミダゾ［１，２−ｂ］ピリダジン誘導体およびＰＤＥ１０阻害剤としてのそれらの使用
|
|
EP2332917B1
(en)
*
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
|
FR2952934B1
(fr)
*
|
2009-11-23 |
2012-06-22 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
CN103221392B
(zh)
|
2010-11-17 |
2015-06-03 |
埃科特莱茵药品有限公司 |
桥联螺[2.4]庚酯衍生物
|
|
WO2012154274A1
(en)
|
2011-02-25 |
2012-11-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
|
EP2524915A1
(en)
|
2011-05-20 |
2012-11-21 |
Sanofi |
2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
|
|
EP2723744B1
(en)
|
2011-06-27 |
2016-03-23 |
Janssen Pharmaceutica, N.V. |
1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
|
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
|
WO2013007768A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
|
|
SI2766359T1
(sl)
|
2011-10-14 |
2016-09-30 |
Ambit Biosciences Corporation |
Heterociklične spojine in njihova uporaba kot modulatorjev receptorja tirozin kinaze tipa III
|
|
MA37618B1
(fr)
|
2012-05-16 |
2017-08-31 |
Actelion Pharmaceuticals Ltd |
Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx
|
|
HK1206250A1
(en)
|
2012-06-26 |
2016-01-08 |
Janssen Pharmaceutica Nv |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and ped 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
|
BR112015000459B1
(pt)
|
2012-07-09 |
2022-02-08 |
Janssen Pharmaceutica N.V. |
Inibidores da enzima fosfodiesterase 10, seu uso, composição farmacêutica que os compreende, seus processo de preparação e produto
|
|
WO2014051698A1
(en)
|
2012-09-28 |
2014-04-03 |
Vanderbilt University |
Fused heterocyclic compounds as selective bmp inhibitors
|
|
ES2649156T3
(es)
|
2013-01-14 |
2018-01-10 |
Incyte Holdings Corporation |
Compuestos bicíclicos de carboxamida aromática útiles como inhibidores de quinasas Pim
|
|
US9200004B2
(en)
|
2013-01-15 |
2015-12-01 |
Incyte Holdings Corporation |
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
|
|
PE20160532A1
(es)
|
2013-08-23 |
2016-05-21 |
Incyte Corp |
Compuesto de carboxamida de furo y tienopiridina utiles como inhibidores de cinasas pim
|
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
CN104597194B
(zh)
*
|
2015-01-15 |
2016-07-06 |
武汉轻工大学 |
3-氯-1，2-丙二醇的高效液相色谱-荧光检测方法
|
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
|
WO2017059251A1
(en)
|
2015-10-02 |
2017-04-06 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|
|
IL273428B2
(en)
|
2017-09-22 |
2023-09-01 |
Jubilant Epipad LLC |
Heterocyclic compounds as pad inhibitors
|
|
AU2018352142B2
(en)
|
2017-10-18 |
2022-08-25 |
Jubilant Epipad LLC |
Imidazo-pyridine compounds as PAD inhibitors
|
|
CA3080677A1
(en)
|
2017-11-06 |
2019-05-09 |
Jubilant Prodel LLC |
Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation
|
|
SMT202400203T1
(it)
|
2017-11-24 |
2024-07-09 |
Jubilant Episcribe Llc |
Composti eterociclici come inibitori di prmt5
|
|
TW201924683A
(zh)
|
2017-12-08 |
2019-07-01 |
美商英塞特公司 |
用於治療骨髓增生性贅瘤的低劑量組合療法
|
|
MX2020009517A
(es)
|
2018-03-13 |
2021-01-20 |
Jubilant Prodel LLC |
Compuestos biciclicos como inhibidores de la interaccion/activacio n de pdl/pd-l1.
|
|
US10745400B2
(en)
|
2018-03-14 |
2020-08-18 |
Vanderbuilt University |
Inhibition of BMP signaling, compounds, compositions and uses thereof
|
|
CN110833556A
(zh)
*
|
2018-08-15 |
2020-02-25 |
广西梧州制药（集团）股份有限公司 |
吡唑并嘧啶衍生物在治疗肝纤维化的用途
|
|
JP2023536920A
(ja)
*
|
2020-08-05 |
2023-08-30 |
ザ ジェネラル ホスピタル コーポレイション |
塩誘導性キナーゼ阻害剤
|